Citation: Z. Babaloo et al., Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th-2 and Th-1 cytokines, T RS TROP M, 95(1), 2001, pp. 85-88
Citation: Ce. Alexander et al., CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice, EUR J IMMUN, 31(4), 2001, pp. 1199-1210
Citation: S. Stager et al., Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis, J IMMUNOL, 165(12), 2000, pp. 7064-7071
Citation: Sc. Smelt et al., B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology, J IMMUNOL, 164(7), 2000, pp. 3681-3688
Citation: Sej. Coterell et al., Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani, INFEC IMMUN, 68(4), 2000, pp. 1840-1848
Citation: Sej. Cotterell et al., Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha, BLOOD, 95(5), 2000, pp. 1642-1651
Citation: Sej. Cotterell et al., Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner, EUR J IMMUN, 29(1), 1999, pp. 203-214